Search results for "Test sensitivity"

showing 5 items of 5 documents

Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patien…

2021

Objectives There is limited information on the performance of rapid antigen detection (RAD) tests to identify SARS-CoV-2-infected asymptomatic individuals. In this field study, we evaluated the Panbio™ COVID-19 Ag Rapid Test Device (Abbott Diagnostics, Jena, Germany) for this purpose. Methods A total of 634 individuals (355 female; median age, 37 years; range, 9–87) were enrolled. Two nasopharyngeal swabs were collected from household (n = 338) and non-household contacts (n = 296) of COVID-19 cases. RAD testing was carried out at the point of care. The RT-PCR test used was the TaqPath COVID-19 Combo Kit (Thermo Fisher Scientific, MA, USA). Results Household contacts were tested at a median …

0301 basic medicineMicrobiology (medical)AdultMale2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Rapid antigen detection testAdolescentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Point-of-Care Systems030106 microbiologyTest sensitivityImmunologic TestsAsymptomaticSensitivity and Specificity03 medical and health sciencesYoung Adult0302 clinical medicineCOVID-19 TestingInternal medicineMedicineHumans030212 general & internal medicineChildAntigens ViralAsymptomatic InfectionsAgedAged 80 and overImmunoassayFamily Characteristicsbusiness.industrySARS-CoV-2COVID-19General MedicineMiddle AgedTest (assessment)AsymptomaticResearch NoteInfectious DiseasesRapid antigen testCOVID-19 Nucleic Acid TestingClose contactsFemalemedicine.symptomContact TracingbusinessContact tracingClinical Microbiology and Infection
researchProduct

Real-life evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID…

2020

ABSTRACTObjectivesThere is limited information on the performance of rapid antigen detection (RAD) tests to identify SARS-CoV-2-infected asymptomatic individuals. In this field study, we evaluated the Panbio™ COVID-19 Ag Rapid Test Device (Abbott Diagnostics, Jena, Germany) for the purpose.MethodsA total of 634 individuals (355 female; median age, 37 years; range, 9-87) were enrolled. Household (n=338) contacts were tested at a median of 2 days (range, 1-7) after diagnosis of the index case and non-household contacts (n=296) at a median of 6 days (range, 1-7) after exposure. RAD testing was carried out at the point of care. The RT-PCR test used was the TaqPath COVID-19 Combo Kit (Thermo Fis…

2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Test sensitivityAsymptomaticTest (assessment)Life evaluationRapid antigen testInternal medicinemedicinemedicine.symptombusiness
researchProduct

Accuracy, Reliability, and Safety of Luminol in Bloodstain Investigation

2002

ABSTRACTThe reliability of luminol as a presumptive test reagent was studied in this work. The possibility of obtaining a false negative subsequent to contamination of the test specimen was determined. The behavior of luminol with respect to a contaminant was compared to other reagents used in similar tests. Following an analysis of the test results, other test sensitivity, and safety data, it was concluded that luminol is a more reliable reagent than others due to a higher improbability of producing false positives and false negatives, apart from being safer than other substances. It should, therefore, be considered as a “preferable” or “first choice” reagent for use in presumptive tests.

ChromatographyInjury controlAccident preventionbusiness.industryFalse positives and false negativesEnvironmental engineeringnutritional and metabolic diseasesPoison controlchemical and pharmacologic phenomenaTest sensitivityPathology and Forensic MedicineLuminolchemistry.chemical_compoundchemistryReagentMedicinebusinessReliability (statistics)Canadian Society of Forensic Science Journal
researchProduct

Inter-laboratory validation of procedures for measuring 8-oxo-7,8-dihydroguanine/8-oxo-7,8-dihydro-2’-deoxyguanosine in DNA.

2002

The aim of ESCODD, a European Commission funded Concerted Action, is to improve the precision and accuracy of methods for measuring 8-oxo-7,8-dihydroguanine (8-oxoGua) or the nucleoside (8-oxodG). On two occasions, participating laboratories received samples of different concentrations of 8-oxodG for analysis. About half the results returned (for 8-oxodG) were within 20% of the median values. Coefficients of variation (for three identical samples) were commonly around 10%. A sample of calf thymus DNA was sent, dry, to all laboratories. Analysis of 8-oxoGua/8-oxodG in this sample was a test of hydrolysis methods. Almost half the reported results were within 20% of the median value, and half …

GuanineAnalytical chemistryTest sensitivityThymus GlandSensitivity and SpecificityBiochemistryGas Chromatography-Mass SpectrometryMass SpectrometryOxidative dna damagechemistry.chemical_compound8 oxo 7 8 dihydroguanineAnimalsHumansEuropean commissionInter-laboratoryChromatography High Pressure LiquidChromatographyChemistry8 oxo 7 8 dihydro 2 deoxyguanosineDNAGeneral MedicineCattleBiomarkersDNAChromatography LiquidDNA Damage
researchProduct

La valutazione neuropsicologica tra significatività statistica e clinica

2008

Aspetti statistici e clinici pervadono tutte le fasi della valutazione neuropsicologica, dalla scelta dei test alla loro restituzione. Il presente articolo, utilizzando i dati di due ricerche come esempio, mette in evidenza l’importanza di ognuno dei due aspetti e di come questi influenzino le diverse fasi del processo di valutazione neuropsicologica e soprattutto la decisione finale e l’eventuale intervento.

Neuropsychological assessment statistical significance clinical significance neuropsychological profiles test sensitivity
researchProduct